Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 329

    1.

    Wild-type and missense mutants of retinoschisin co-assemble resulting in either intra-cellular retention or incorrect assembly of the functionally active octomer.

    Gleghorn LJ, Trump D, Bulleid NJ.

    Biochem J. 2009 Oct 22. [Epub ahead of print]PMID: 19849666 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Fibulin 5 forms a compact dimer in physiological solutions.

    Jones RP, Wang MC, Jowitt TA, Ridley C, Mellody KT, Howard M, Wang T, Bishop PN, Lotery AJ, Kielty CM, Baldock C, Trump D.

    J Biol Chem. 2009 Sep 18;284(38):25938-43. Epub 2009 Jul 17.PMID: 19617354 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Differential regulation of elastic fiber formation by fibulin-4 and -5.

    Choudhury R, McGovern A, Ridley C, Cain SA, Baldwin A, Wang MC, Guo C, Mironov A Jr, Drymoussi Z, Trump D, Shuttleworth A, Baldock C, Kielty CM.

    J Biol Chem. 2009 Sep 4;284(36):24553-67. Epub 2009 Jul 1.PMID: 19570982 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.

    Sonpavde G, Goldman BH, Speights VO, Lerner SP, Wood DP, Vogelzang NJ, Trump DL, Natale RB, Grossman HB, Crawford ED.

    Cancer. 2009 Sep 15;115(18):4104-9.PMID: 19517476 [PubMed - indexed for MEDLINE]Related articles

    5.

    Vitamin D deficiency and insufficiency among patients with prostate cancer.

    Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS.

    BJU Int. 2009 Apr 4. [Epub ahead of print]PMID: 19426195 [PubMed - as supplied by publisher]Related articles

    6.

    A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.

    Muindi JR, Johnson CS, Trump DL, Christy R, Engler KL, Fakih MG.

    Cancer Chemother Pharmacol. 2009 Dec;65(1):33-40. Epub 2009 Apr 26.PMID: 19396601 [PubMed - indexed for MEDLINE]Related articles

    7.

    Bladder cancer.

    Montie JE, Clark PE, Eisenberger MA, El-Galley R, Greenberg RE, Herr HW, Hudes GR, Kuban DA, Kuzel TM, Lange PH, Lele SM, Michalski J, Patterson A, Pohar KS, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2009 Jan;7(1):8-39. No abstract available. PMID: 19176203 [PubMed - indexed for MEDLINE]Related articles

    8.

    Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

    Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, Trump DL, Johnson CS.

    Cancer Res. 2009 Feb 1;69(3):967-75. Epub 2009 Jan 13.PMID: 19141646 [PubMed - indexed for MEDLINE]Related articles

    9.

    Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy.

    Shah SK, Trump DL, Sartor O, Tan W, Wilding GE, Mohler JL.

    J Urol. 2009 Feb;181(2):621-6. Epub 2008 Dec 16.PMID: 19091347 [PubMed - indexed for MEDLINE]Related articles

    10.

    Retinoschisin, a new binding partner for L-type voltage-gated calcium channels in the retina.

    Shi L, Jian K, Ko ML, Trump D, Ko GY.

    J Biol Chem. 2009 Feb 6;284(6):3966-75. Epub 2008 Dec 11.PMID: 19074145 [PubMed - indexed for MEDLINE]Related articles

    11.

    A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.

    Lau YK, Chadha MK, Litwin A, Trump DL.

    J Hematol Oncol. 2008 Nov 5;1:21.PMID: 18986533 [PubMed - in process]Related articlesFree article

    12.

    Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer.

    Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY.

    Int J Colorectal Dis. 2009 Feb;24(2):219-24. Epub 2008 Oct 2.PMID: 18830610 [PubMed - indexed for MEDLINE]Related articles

    13.

    Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.

    Greenspan SL, Nelson JB, Trump DL, Wagner JM, Miller ME, Perera S, Resnick NM.

    J Clin Oncol. 2008 Sep 20;26(27):4426-34.PMID: 18802155 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.

    Ma Y, Yu WD, Hershberger PA, Flynn G, Kong RX, Trump DL, Johnson CS.

    Mol Cancer Ther. 2008 Sep;7(9):3047-55.PMID: 18790784 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Phase II study of fulvestrant (Faslodex) in castration resistant prostate cancer.

    Chadha MK, Ashraf U, Lawrence D, Tian L, Levine E, Silliman C, Escott P, Payne V, Trump DL.

    Prostate. 2008 Sep 15;68(13):1461-6.PMID: 18618738 [PubMed - indexed for MEDLINE]Related articles

    16.

    Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel.

    Zhang Y, Wang T, Ma A, Zhou X, Gui J, Wan H, Shi R, Huang C, Grace AA, Huang CL, Trump D, Zhang H, Zimmer T, Lei M.

    Acta Physiol (Oxf). 2008 Dec;194(4):311-23. Epub 2008 Jul 24.PMID: 18616619 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Phenotype-specific CpG island methylation events in a murine model of prostate cancer.

    Camoriano M, Kinney SR, Moser MT, Foster BA, Mohler JL, Trump DL, Karpf AR, Smiraglia DJ.

    Cancer Res. 2008 Jun 1;68(11):4173-82.PMID: 18519676 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Circadian regulation of retinoschisin in the chick retina.

    Ko ML, Liu Y, Shi L, Trump D, Ko GY.

    Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1615-21.PMID: 18385082 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts.

    Atkinson DM, Clarke MJ, Mladek AC, Carlson BL, Trump DP, Jacobson MS, Kemp BJ, Lowe VJ, Sarkaria JN.

    Head Neck. 2008 Jun;30(6):790-9.PMID: 18286491 [PubMed - indexed for MEDLINE]Related articles

    20.

    Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.

    Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, McCann E, Trump D, Prescott T, Evans DG.

    J Med Genet. 2008 Jun;45(6):332-9. Epub 2008 Feb 19. Erratum in: J Med Genet. 2008 Sep;45(9):608. PMID: 18285426 [PubMed - indexed for MEDLINE]Related articles

    21.

    In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors.

    Rassnick KM, Muindi JR, Johnson CS, Balkman CE, Ramnath N, Yu WD, Engler KL, Page RL, Trump DL.

    Cancer Chemother Pharmacol. 2008 Oct;62(5):881-91. Epub 2008 Feb 2.PMID: 18246349 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    An overview of Notch3 function in vascular smooth muscle cells.

    Wang T, Baron M, Trump D.

    Prog Biophys Mol Biol. 2008 Jan-Apr;96(1-3):499-509. Epub 2007 Jul 29. Review.PMID: 17854869 [PubMed - indexed for MEDLINE]Related articles

    23.

    Allelic variation of the FRMD7 gene in congenital idiopathic nystagmus.

    Self JE, Shawkat F, Malpas CT, Thomas NS, Harris CM, Hodgkins PR, Chen X, Trump D, Lotery AJ.

    Arch Ophthalmol. 2007 Sep;125(9):1255-63.PMID: 17846367 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Notch3 activation modulates cell growth behaviour and cross-talk to Wnt/TCF signalling pathway.

    Wang T, Holt CM, Xu C, Ridley C, P O Jones R, Baron M, Trump D.

    Cell Signal. 2007 Dec;19(12):2458-67. Epub 2007 Aug 3.PMID: 17822871 [PubMed - indexed for MEDLINE]Related articles

    25.

    Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.

    Deeb KK, Trump DL, Johnson CS.

    Nat Rev Cancer. 2007 Sep;7(9):684-700. Review.PMID: 17721433 [PubMed - indexed for MEDLINE]Related articles

    26.

    Progress in defining the molecular biology of age related macular degeneration.

    Lotery A, Trump D.

    Hum Genet. 2007 Nov;122(3-4):219-36. Epub 2007 Jul 21. Review.PMID: 17659362 [PubMed - indexed for MEDLINE]Related articles

    27.

    Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.

    Hussain MH, MacVicar GR, Petrylak DP, Dunn RL, Vaishampayan U, Lara PN Jr, Chatta GS, Nanus DM, Glode LM, Trump DL, Chen H, Smith DC; National Cancer Institute.

    J Clin Oncol. 2007 Jun 1;25(16):2218-24. Erratum in: J Clin Oncol. 2008 Jul 1;26(19): 3295. PMID: 17538166 [PubMed - indexed for MEDLINE]Related articles

    28.

    Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation.

    Gupta S, Silliman CG, Trump DL.

    Prostate Cancer Prostatic Dis. 2007;10(4):396-7. Epub 2007 Apr 3.PMID: 17404582 [PubMed - indexed for MEDLINE]Related articles

    29.

    Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial.

    Greenspan SL, Nelson JB, Trump DL, Resnick NM.

    Ann Intern Med. 2007 Mar 20;146(6):416-24.PMID: 17371886 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments.

    Chung I, Yu WD, Karpf AR, Flynn G, Bernardi RJ, Modzelewski RA, Johnson CS, Trump DL.

    J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):768-70. Review.PMID: 17368191 [PubMed - indexed for MEDLINE]Related articles

    31.

    Altered VDR-mediated transcriptional activity in prostate cancer stroma.

    Hidalgo AA, Paredes R, Garcia VM, Flynn G, Johnson CS, Trump DL, Onate SA.

    J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):731-6.PMID: 17368189 [PubMed - indexed for MEDLINE]Related articles

    32.

    CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines.

    Muindi JR, Nganga A, Engler KL, Coignet LJ, Johnson CS, Trump DL.

    J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):334-7.PMID: 17368180 [PubMed - indexed for MEDLINE]Related articles

    33.

    A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.

    Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, Schwartz J, Brattain MG, Hutson A, French R, Johnson CS.

    Clin Cancer Res. 2007 Feb 15;13(4):1216-23.PMID: 17317832 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    X-linked retinoschisis in a female with a heterozygous RS1 missense mutation.

    Saldana M, Thompson J, Monk E, Trump D, Long V, Sheridan E.

    Am J Med Genet A. 2007 Mar 15;143(6):608-9. No abstract available. PMID: 17304551 [PubMed - indexed for MEDLINE]Related articles

    35.

    Characterization of Vitamin D insensitive prostate cancer cells.

    Alagbala AA, Moser MT, Johnson CS, Trump DL, Foster BA.

    J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):712-6. Epub 2007 Feb 5.PMID: 17280828 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol.

    Chung I, Karpf AR, Muindi JR, Conroy JM, Nowak NJ, Johnson CS, Trump DL.

    J Biol Chem. 2007 Mar 23;282(12):8704-14. Epub 2007 Jan 22.PMID: 17244627 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.

    Alagbala AA, Johnson CS, Trump DL, Posner GH, Foster BA.

    Oncology. 2006;70(6):483-92. Epub 2007 Jan 18.PMID: 17237623 [PubMed - indexed for MEDLINE]Related articles

    38.

    Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.

    Flynn G, Chung I, Yu WD, Romano M, Modzelewski RA, Johnson CS, Trump DL.

    Oncology. 2006;70(6):447-57. Epub 2007 Jan 19.PMID: 17237620 [PubMed - indexed for MEDLINE]Related articles

    39.

    X-linked retinoschisis: an update.

    Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D.

    J Med Genet. 2007 Apr;44(4):225-32. Epub 2006 Dec 15. Review.PMID: 17172462 [PubMed - indexed for MEDLINE]Related articles

    40.

    Bladder cancer. Clinical guidelines in oncology.

    Montie JE, Abrahams NA, Bahnson RR, Eisenberger MA, El-Galley R, Herr HW, Hudes GR, Kuzel TM, Lange PH, Patterson A, Pollack A, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2006 Nov;4(10):984-1014. No abstract available. PMID: 17112448 [PubMed - indexed for MEDLINE]Related articles

    41.

    Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer.

    Beer TM, Javle MM, Ryan CW, Garzotto M, Lam GN, Wong A, Henner WD, Johnson CS, Trump DL.

    Cancer Chemother Pharmacol. 2007 Apr;59(5):581-7. Epub 2006 Oct 26.PMID: 17066293 [PubMed - indexed for MEDLINE]Related articles

    42.

    Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genes.

    Naseem H, Boylan J, Speake D, Leask K, Shenton A, Lalloo F, Hill J, Trump D, Evans DG.

    Clin Genet. 2006 Nov;70(5):388-95.PMID: 17026620 [PubMed - indexed for MEDLINE]Related articles

    43.

    Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.

    Chung I, Wong MK, Flynn G, Yu WD, Johnson CS, Trump DL.

    Cancer Res. 2006 Sep 1;66(17):8565-73.PMID: 16951169 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Self-rated health and health care utilization after military deployments.

    Trump DH.

    Mil Med. 2006 Jul;171(7):662-8.PMID: 16895138 [PubMed - indexed for MEDLINE]Related articles

    46.

    Vitamin D compounds: clinical development as cancer therapy and prevention agents.

    Trump DL, Muindi J, Fakih M, Yu WD, Johnson CS.

    Anticancer Res. 2006 Jul-Aug;26(4A):2551-6.PMID: 16886663 [PubMed - indexed for MEDLINE]Related articles

    47.

    The antitumor efficacy of calcitriol: preclinical studies.

    Johnson CS, Muindi JR, Hershberger PA, Trump DL.

    Anticancer Res. 2006 Jul-Aug;26(4A):2543-9. Review.PMID: 16886662 [PubMed - indexed for MEDLINE]Related articles

    48.

    Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction.

    Zmuda JM, Modugno F, Weissfeld JL, Cauley JA, Trump DL, Moffett SP, Ferrell RE.

    Oncology. 2006;70(3):185-9. Epub 2006 Jun 7.PMID: 16763406 [PubMed - indexed for MEDLINE]Related articles

    49.

    Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.

    Messing EM, Manola J, Yao J, Kiernan M, Crawford D, Wilding G, di'SantAgnese PA, Trump D; Eastern Cooperative Oncology Group study EST 3886.

    Lancet Oncol. 2006 Jun;7(6):472-9.PMID: 16750497 [PubMed - indexed for MEDLINE]Related articles

    50.

    Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.

    Muindi JR, Peng Y, Wilson JW, Johnson CS, Branch RA, Trump DL.

    Cancer Chemother Pharmacol. 2007 Jan;59(1):97-104. Epub 2006 May 6.PMID: 16680461 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...